A new study published in Engineering has identified enolase 2 (ENO2) as a key factor in the lymphatic metastasis of head and ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck ...

On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell ...

Squamous cell cancer (SCC) is a type of skin cancer. To determine the severity of SCC, doctors use a staging system. There are five stages in total, ranging from 0 to 4. SCC stages describe the ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 ...

Neoadjuvant chemoimmunotherapy is associated with significantly improved survival outcomes compared with standard ...

The reported risk for metastasis in squamous cell carcinomas (SCCs) ranges from 0.5% to 16%, a wide spread that can probably be explained by differences in patient populations. Identifying the ...